![Pinnacle Clinical Research, a Portfolio Company of LongueVue Capital, Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network to Expand its CNS Trial Execution Capabilities](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(49).png)
Insights
![Pinnacle Clinical Research, a Portfolio Company of LongueVue Capital, Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network to Expand its CNS Trial Execution Capabilities](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(49).png)
Deal Insights
Pinnacle Clinical Research, a Portfolio Company of LongueVue Capital, Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network to Expand its CNS Trial Execution Capabilities
Learn More
![Pinnacle Clinical Research, a Portfolio Company of LongVue Capital, Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network and Trial Execution Capabilities](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(48).png)
Deal Insights
Pinnacle Clinical Research, a Portfolio Company of LongVue Capital, Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network and Trial Execution Capabilities
Pinnacle Clinical Research, a Portfolio Company of LongVue Capital, Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network and Trial Execution Capabilities
Learn More
![Pharma Services June 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(50).png)
BlueBook
Pharma Services June 2024
Highlights from this edition: Pro-Ficiency Holdings was acquired by Simulations Plus, Inc. (NasdaqGS:SLP), Integral Diagnostics Limited (ASX:IDX) announced its acquisition of Capitol Health Limited (ASX:CAJ), Trialspark closed a $372MM Series A Financing, led by Sequoia Capital Operations LLC, Sanofi (ENXTPA:SAN), Andreessen Horowitz LLC, SV Angel, Thrive Capital Management, LLC, Emerson Collective, LLC, FPV Ventures, LLC
Download Now
![Diagnostics and Tools June 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(51).png)
BlueBook
Diagnostics and Tools June 2024
Highlights from this edition: Moleculent closed a $26MM Series A Financing, led by Arch Venture Partners, RareCyte closed a $20MM Growth Financing, led by Agilent Technologies, Inc. (NYSE:A), 5AM Venture Management, Arboretum Ventures, HealthQuest Capital, Impresa Management, Forest Road Company, Sheatree Capital, Gkcc, BillionToOne, Inc. closed a $130MM Series D Financing, led by Premji Invest Limited
Download Now
![BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(40).png)
Deal Insights
BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering
BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering
Learn More
![Pharma Services May 2024](https://www.crosstreecapital.com/hubfs/Untitled%20design%20(42).png)
BlueBook
Pharma Services May 2024
Highlights from this edition: Blackstone Inc. (NYSE:BX) announced its acquisition of I'rom Group Co., Ltd. (TSE:2372), Sift Medical Data, Inc. closed a $20MM Series A Financing, led by Allos Ventures, B Capital Group Management, L.P., First Trust Capital Partners LLC, Rock River Capital Partners
Download Now
/
6
Load More
Gain Insight Into The Health
Sciences Industries
Sign up to receive the the latest reports, research, BlueBooks, and more from the Crosstree team.